• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T - 1583与福斯高林在心脏效应方面相似,而在血管效应方面不同。

T-1583 and forskolin are similar in their cardiac effects and dissimilar in their vascular effects.

作者信息

Hosono M, Satoh K, Taira N

机构信息

Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan.

出版信息

Cardiovasc Drugs Ther. 1988 Jul;2(2):245-53. doi: 10.1007/BF00051241.

DOI:10.1007/BF00051241
PMID:2908722
Abstract

The cardiac and coronary vascular effects of T-1583, a selective beta 1-adrenoceptor full agonist, and forskolin, a direct activator of adenylate cyclase, were compared in isolated, blood-perfused papillary muscle, sinoatrial node, and atrioventricular (AV) node preparations of dogs. Both agents were injected intra-arterially. The two agents increased the force of contraction of the paced papillary muscle and the unpaced one, and the rate of automaticity of the latter. They increased sinus rate and accelerated AV nodal conduction. In producing these effects T-1583 was 50 to 80 times more potent than forskolin, indicating that both agents have similar cardiac profiles. At the doses that produced a 50% increase in the force of contraction of the papillary muscle, both agents produced about a 20% increase in sinus rate. Such degrees of force-rate separation were close to those obtained with most new positive inotropic agents with an inhibitory action on cyclic AMP phosphodiesterase. T-1583 differed distinctly from forskolin in that the former increased only slightly coronary blood flow, whereas the latter increased it greatly. Thus, forskolin is more coronary vasodilatory than positively inotropic, and more positively inotropic than positively chronotropic. T-1583 is a more positively inotropic than positively chronotropic and more positively chronotropic than coronary vasodilatory.

摘要

在犬离体、血液灌注的乳头肌、窦房结和房室(AV)结标本中,比较了选择性β1肾上腺素能受体完全激动剂T-1583和腺苷酸环化酶直接激活剂福斯高林对心脏和冠状血管的作用。两种药物均经动脉内注射。这两种药物均可增加起搏乳头肌和未起搏乳头肌的收缩力以及后者的自律性。它们可增加窦性心率并加速房室结传导。在产生这些作用时,T-1583的效力比福斯高林强50至80倍,表明这两种药物具有相似的心脏作用模式。在使乳头肌收缩力增加50%的剂量下,两种药物均可使窦性心率增加约20%。这种程度的力-率分离与大多数对环磷酸腺苷磷酸二酯酶有抑制作用的新型正性肌力药物所获得的结果相近。T-1583与福斯高林明显不同,前者仅使冠状动脉血流量略有增加,而后者使其大幅增加。因此,福斯高林的冠状动脉舒张作用强于正性肌力作用,正性肌力作用强于正性变时作用。T-1583的正性肌力作用强于正性变时作用,正性变时作用强于冠状动脉舒张作用。

相似文献

1
T-1583 and forskolin are similar in their cardiac effects and dissimilar in their vascular effects.T - 1583与福斯高林在心脏效应方面相似,而在血管效应方面不同。
Cardiovasc Drugs Ther. 1988 Jul;2(2):245-53. doi: 10.1007/BF00051241.
2
Profile of cardiovascular effects of NKH477, a novel forskolin derivative, assessed in isolated, blood-perfused dog heart preparations: comparison with isoproterenol.新型福司可林衍生物NKH477在离体血液灌注犬心制备物中的心血管效应概况:与异丙肾上腺素的比较
J Cardiovasc Pharmacol. 1992 Aug;20(2):261-7. doi: 10.1097/00005344-199208000-00011.
3
Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.新型哒嗪酮衍生物6-[4-[2-[3-(5-氯-2-氰基苯氧基)-2-羟丙基氨基]-2-甲基丙基氨基]苯基]-4,5-二氢-5-甲基-3(2H)哒嗪酮马来酸单乙酯及其代谢产物对豚鼠和犬离体心脏标本的心脏效应
Arzneimittelforschung. 1994 May;44(5):583-8.
4
Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.新型亲水性1,4-二氢吡啶衍生物NKY-722在血液灌注犬心脏中的冠状血管舒张和心脏效应
Cardiovasc Drugs Ther. 1989 Mar;3(1):81-90. doi: 10.1007/BF01881532.
5
Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.抗心动过速药阿利尼定对离体血液灌注犬心标本中窦房结自律性及其他心脏活动的选择性。
Arch Int Pharmacodyn Ther. 1984 Nov;272(1):88-102.
6
Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.新型二氢吡啶类钙拮抗剂PN 200 - 110在犬心脏中冠状动脉扩张作用与心脏效应的分离
J Cardiovasc Pharmacol. 1985 Jan-Feb;7(1):190-6. doi: 10.1097/00005344-198501000-00030.
7
Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.新型二氢吡啶血管扩张剂PY 108 - 068对离体血液灌注犬心制剂的心脏效应与冠状动脉血管扩张剂的比较。
J Cardiovasc Pharmacol. 1984 Sep-Oct;6(5):881-7. doi: 10.1097/00005344-198409000-00022.
8
Comparative study of cardiovascular profiles of milrinone and amrinone by use of isolated, blood-perfused dog heart preparations.使用离体血液灌注犬心制备物对米力农和氨力农心血管特性的比较研究。
Heart Vessels. 1986;2(4):213-20. doi: 10.1007/BF02059971.
9
Inotropic versus chronotropic, dromotropic, and coronary vasodilator actions of DPI 201-106, a novel positive inotropic agent, in the dog heart.新型正性肌力药物DPI 201-106在犬心脏中的正性肌力作用与变时性、变传导性及冠状血管舒张作用对比
J Cardiovasc Pharmacol. 1987 Apr;9(4):451-60. doi: 10.1097/00005344-198704000-00010.
10
Cardiac and coronary vasodilator effects of the novel cardiotonic agent, MCI-154, assessed in isolated, blood-perfused dog heart preparations.新型强心剂MCI - 154对心脏和冠状动脉的血管舒张作用,在离体血液灌注犬心制备中进行评估。
J Cardiovasc Pharmacol. 1987 Dec;10(6):692-8. doi: 10.1097/00005344-198712000-00013.

本文引用的文献

1
The positive inotropic-acting forskolin, a potent adenylate cyclase activator.具有正性肌力作用的福斯高林,一种有效的腺苷酸环化酶激活剂。
Arzneimittelforschung. 1981;31(8):1248-50.
2
Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)对犬心脏的作用方式及作用机制
Arzneimittelforschung. 1984;34(3A):347-55.
3
Coronary physiology.冠状动脉生理学
Physiol Rev. 1983 Jan;63(1):1-205. doi: 10.1152/physrev.1983.63.1.1.
4
Forskolin: a unique diterpene activator of cyclic AMP-generating systems.福司可林:一种独特的环磷酸腺苷生成系统二萜激活剂。
J Cyclic Nucleotide Res. 1981;7(4):201-24.
5
Inhibition of smooth muscle tension by cyclic AMP-dependent protein kinase.环磷酸腺苷依赖性蛋白激酶对平滑肌张力的抑制作用。
Nature. 1981 Jul 16;292(5820):253-5. doi: 10.1038/292253a0.
6
The relationship between calmodulin binding and phosphorylation of smooth muscle myosin kinase by the catalytic subunit of 3':5' cAMP-dependent protein kinase.3':5' 环磷酸腺苷(cAMP)依赖性蛋白激酶催化亚基对平滑肌肌球蛋白激酶的钙调蛋白结合与磷酸化之间的关系。
J Biol Chem. 1981 Apr 10;256(7):3178-81.
7
Cardiovascular effects of a new positive inotropic agent, (-)-(R)-1-(p-hydroxyphenyl)-2-[(3,4-dimethoxyphenethyl)amino]-ethanol (TA-064) in the anesthetized dog and isolated guinea pig heart.新型正性肌力药物(-)-(R)-1-(对羟基苯基)-2- [(3,4-二甲氧基苯乙基)氨基] -乙醇(TA-064)对麻醉犬和离体豚鼠心脏的心血管作用
Jpn J Pharmacol. 1984 Aug;35(4):415-23. doi: 10.1254/jjp.35.415.
8
Characterization of beta-adrenoceptors in the dog saphenous vein.犬隐静脉中β-肾上腺素能受体的特性研究
Jpn J Pharmacol. 1981 Oct;31(5):731-6. doi: 10.1254/jjp.31.731.
9
Comparison of the cardiovascular and biochemical profiles of a new positive inotropic drug, AR-L 115 BS, with those of theophylline.新型强心药物AR-L 115 BS与茶碱的心血管和生化特征比较。
Jpn Heart J. 1984 May;25(3):447-60. doi: 10.1536/ihj.25.447.
10
The isolated and cross-circulated AV node preparation of the dog.犬的离体和交叉循环房室结标本
Tohoku J Exp Med. 1972 Jul;107(3):263-75. doi: 10.1620/tjem.107.263.